Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Randall J Bateman

Showing results (271-280 of 391) with videos related to

Pageof 40
Sort By:
Scientific Reports|April 29, 2017
Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer's diseaseStephan Müller, Oliver Preische, Hamid R Sohrabi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 30, 2018
Relationship between physical activity, cognition, and Alzheimer pathology in autosomal dominant Alzheimer's diseaseStephan Müller, Oliver Preische, Hamid R Sohrabi, et al.
The Journal of Prevention of Alzheimer'S Disease|January 1, 2026
Plasma Aβ42/40 predicts progression from Aβ-amyloid negative to positive PET scansAzadeh Feizpour, Vincent Doré, Pierrick Bourgeat, et al.
Nature Communications|April 21, 2023
Single-nucleus RNA-sequencing of autosomal dominant Alzheimer disease and risk variant carriersLogan Brase, Shih-Feng You, Ricardo D'Oliveira Albanus, et al.
Brain : a Journal of Neurology|August 4, 2022
Accelerated longitudinal changes and ordering of Alzheimer disease biomarkers across the adult lifespanJingqin Luo, Folasade Agboola, Elizabeth Grant, et al.
EMBO Molecular Medicine|November 29, 2018
CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive declineMarc Suárez-Calvet, Anja Capell, Miguel Ángel Araque Caballero, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 24, 2025
Evaluation of exploratory fluid biomarkers from a phase 1 senolytic trial in mild Alzheimer's diseaseValentina R Garbarino, Juan Pablo Palavicini, Justin Melendez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 24, 2024
Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's diseaseGuoqiao Wang, Yan Li, Chengjie Xiong, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 8, 2026
Plasma levels of an N-terminal tau fragment predict Alzheimer's and neurodegenerative disease biomarkers in autosomal dominant Alzheimer's diseaseStephanie A Schultz, Yiwen Rao, Lei Liu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 12, 2022
Comparative analytical performance of multiple plasma Aβ42 and Aβ40 assays and their ability to predict positron emission tomography amyloid positivityStephen Zicha, Randall J Bateman, Leslie M Shaw, et al.
Pageof 40

Showing results (271-280 of 391) with videos related to

Sort By:
Pageof 40
Scientific Reports|April 29, 2017
Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer's diseaseStephan Müller, Oliver Preische, Hamid R Sohrabi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 30, 2018
Relationship between physical activity, cognition, and Alzheimer pathology in autosomal dominant Alzheimer's diseaseStephan Müller, Oliver Preische, Hamid R Sohrabi, et al.
The Journal of Prevention of Alzheimer'S Disease|January 1, 2026
Plasma Aβ42/40 predicts progression from Aβ-amyloid negative to positive PET scansAzadeh Feizpour, Vincent Doré, Pierrick Bourgeat, et al.
Nature Communications|April 21, 2023
Single-nucleus RNA-sequencing of autosomal dominant Alzheimer disease and risk variant carriersLogan Brase, Shih-Feng You, Ricardo D'Oliveira Albanus, et al.
Brain : a Journal of Neurology|August 4, 2022
Accelerated longitudinal changes and ordering of Alzheimer disease biomarkers across the adult lifespanJingqin Luo, Folasade Agboola, Elizabeth Grant, et al.
EMBO Molecular Medicine|November 29, 2018
CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive declineMarc Suárez-Calvet, Anja Capell, Miguel Ángel Araque Caballero, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 24, 2025
Evaluation of exploratory fluid biomarkers from a phase 1 senolytic trial in mild Alzheimer's diseaseValentina R Garbarino, Juan Pablo Palavicini, Justin Melendez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 24, 2024
Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's diseaseGuoqiao Wang, Yan Li, Chengjie Xiong, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 8, 2026
Plasma levels of an N-terminal tau fragment predict Alzheimer's and neurodegenerative disease biomarkers in autosomal dominant Alzheimer's diseaseStephanie A Schultz, Yiwen Rao, Lei Liu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 12, 2022
Comparative analytical performance of multiple plasma Aβ42 and Aβ40 assays and their ability to predict positron emission tomography amyloid positivityStephen Zicha, Randall J Bateman, Leslie M Shaw, et al.
Pageof 40